(VIANEWS) - NRG Energy (NRG), L.B. Foster Company (FSTR), Norfolk Southern (NSC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NRG Energy (NRG)
83% sales growth and 20.11% return on equity
NRG Energy, Inc., together with its subsidiaries, operates as an energy company in the United States.
NRG Energy's sales growth this year is anticipated to be 119.5% and a negative 22.1% for next year.
Year-on-year quarterly revenue growth grew by 300.7%, now sitting on 15.16B for the twelve trailing months.
Volume
Today's last reported volume for NRG Energy is 1476520 which is 38.48% below its average volume of 2400320.
NRG Energy's sales growth is a negative 0% for the ongoing quarter and 83% for the next. The company's growth estimates for the ongoing quarter and the next is 126.5% and negative -29.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.11%.
Volatility
NRG Energy's last day, last week, and last month's current intraday variation average was 0.29%, 0.99%, and 1.26%, respectively.
NRG Energy's highest amplitude of average volatility was 1.52% (day), 1.49% (last week), and 2.76% (last month), respectively.
NRG Energy's Stock Yearly Top and Bottom Value
NRG Energy's stock is valued at $38.43 at 10:22 EST, way under its 52-week high of $46.10 and way above its 52-week low of $30.47.
NRG Energy's Moving Average
NRG Energy's worth is below its 50-day moving average of $40.34 and below its 200-day moving average of $39.68.2. L.B. Foster Company (FSTR)
9.9% sales growth and 3.43% return on equity
L.B. Foster Company provides products and services for the rail industry and solutions to support critical infrastructure projects worldwide.
L.B. Foster Company's sales growth this year is anticipated to be 11% and 0.3% for next year.
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 516.23M for the twelve trailing months.
Volume
Today's last reported volume for L.B. Foster Company is 7310 which is 79.6% below its average volume of 35840.
L.B. Foster Company's sales growth for the next quarter is 9.9%. The company's growth estimates for the current quarter and the next is a negative 5% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.43%.
Volatility
L.B. Foster Company's last day, last week, and last month's current intraday variation average was 1.53%, 2.42%, and 2.01%, respectively.
L.B. Foster Company's highest amplitude of average volatility was 5.10% (day), 3.78% (last week), and 4.23% (last month), respectively.
L.B. Foster Company's Stock Yearly Top and Bottom Value
L.B. Foster Company's stock is valued at $15.08 at 10:22 EST, way under its 52-week high of $19.47 and way higher than its 52-week low of $12.62.
L.B. Foster Company's Moving Average
L.B. Foster Company's value is above its 50-day moving average of $14.47 and under its 200-day moving average of $16.40.3. Norfolk Southern (NSC)
8.3% sales growth and 15.61% return on equity
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods in the United States.
Norfolk Southern's sales growth this year is expected to be 12.7% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 9.8B for the twelve trailing months.
Volume
Today's last reported volume for Norfolk Southern is 990236 which is 19.85% below its average volume of 1235540.
Norfolk Southern's sales growth is a negative 0% for the current quarter and 8.3% for the next. The company's growth estimates for the current quarter and the next is 21.5% and 14.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.61%.
Volatility
Norfolk Southern's last day, last week, and last month's current intraday variation average was 1.11%, 1.08%, and 1.48%, respectively.
Norfolk Southern's highest amplitude of average volatility was 2.34% (day), 1.82% (last week), and 2.33% (last month), respectively.
Norfolk Southern's Stock Yearly Top and Bottom Value
Norfolk Southern's stock is valued at $270.22 at 10:22 EST, under its 52-week high of $296.06 and way higher than its 52-week low of $226.09.
Norfolk Southern's Moving Average
Norfolk Southern's value is above its 50-day moving average of $269.34 and higher than its 200-day moving average of $267.33.4. Integra LifeSciences Holdings Corporation (IART)
8.2% sales growth and 14.29% return on equity
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery.
Integra LifeSciences Holdings Corporation's sales growth this year is anticipated to be 12.3% and 5.6% for next year.
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 1.53B for the twelve trailing months.
Volume
Today's last reported volume for Integra LifeSciences Holdings Corporation is 249999 which is 35.7% below its average volume of 388850.
Integra LifeSciences Holdings Corporation's sales growth for the next quarter is 8.2%. The company's growth estimates for the current quarter and the next is a negative 1.2% and 5.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.29%.
Volatility
Integra LifeSciences Holdings Corporation's last day, last week, and last month's current intraday variation average was 0.88%, 0.90%, and 1.20%, respectively.
Integra LifeSciences Holdings Corporation's highest amplitude of average volatility was 2.60% (day), 2.37% (last week), and 3.31% (last month), respectively.
Integra LifeSciences Holdings Corporation's Stock Yearly Top and Bottom Value
Integra LifeSciences Holdings Corporation's stock is valued at $65.61 at 10:22 EST, way below its 52-week high of $77.40 and above its 52-week low of $61.80.